Sites
Tags
- A
- Abciximab
- Ace inhibitor
- Acenocoumarol
- Acetylsalicylic acid/dipyridamole
- Addiction medicine
- Adenosine diphosphate
- Adverse drug reaction
- American Chemical Society
- American Society of Health-System Pharmacists
- Anabolic steroid
- Analgesic
- Anaphylaxis
- Anemia
- Anesthetic
- Angina pectoris
- Angiotensin II receptor antagonist
- Anorectic
- Antacid
- Anthelmintic
- Antiarrhythmic agent
- Antibacterial
- Anticoagulant
- Anticonvulsant
- Antidepressant
- Anti-diabetic medication
- Antidote
- Antiemetic
- Antifibrinolytic
- Antifungal
- Antihemorrhagic
- Antihypertensive drug
- Anti-inflammatory
- Antimetabolite
- Antimicrobial
- Anti-obesity medication
- Antiparasitic
- Antiplatelet drug
- Antiplatelet therapy
- Antiprotozoal
- Antipruritic
- Antipsychotic
- Antithrombin
- Antithrombotic
- Antiviral drug
- Anxiolytic
- Aphrodisiac
- Apixaban
- Argatroban
- Artery
- Aspirin
- ATC code D09
- ATC code V
- Attention deficit hyperactivity disorder
- Beta blocker
- Bile acid sequestrant
- Biological half-life
- Bisphosphonate
- Bivalirudin
- Bleeding
- Blood
- Blood transfusion
- Bone
- Breast milk
- Brinase
- Bronchodilator
- Calcium channel blocker
- Cangrelor
- Cardiac glycoside
- Cardiac stimulant
- Cardiovascular disease
- CAS Registry Number
- Cauda equina syndrome
- Chemical formula
- Chemotherapy
- Chills
- Cilostazol
- Circulatory System
- Citric acid
- Clinical trial
- Clopidogrel
- Clotting time
- Coagulation
- Constitutive androstane receptor
- Contrast medium
- Coronary artery disease
- Corticosteroid
- Cosa
- Cough medicine
- Coumarin
- COVID-19
- Cyclooxygenase
- Dabigatran
- DailyMed
- Dalteparin sodium
- Decongestant
- Defibrotide
- Dementia
- Depressant
- Dicoumarol
- Diphenadione
- Dipyridamole
- Direct thrombin inhibitor
- Disease-modifying antirheumatic drug
- Dissociative
- Diuretic
- DOI
- Dressing
- DrugBank
- Drug nomenclature
- Edoxaban
- Effect
- Empathogen–entactogen
- Endocrine system
- Enoxaparin sodium
- Entheogen
- Eptifibatide
- Ethylenediaminetetraacetic acid
- Euphoria
- European Chemicals Agency
- Factor IX
- Factor VII
- Factor X
- Fertility medication
- Fever
- Fibrate
- Fibrinolysis
- Fondaparinux
- Food and Drug Administration
- Gastrointestinal tract
- General anaesthetic
- Generic drug
- Genitourinary system
- GIF
- Glucocorticoid
- Glycoprotein IIb/IIIa inhibitors
- Glycosaminoglycan
- H1 antagonist
- H2 antagonist
- Haemophilia
- Hallucinogen
- Hematocrit
- Hemoglobin
- Hemostasis
- Heparin
- Hirudin
- Hormonal contraception
- Human brain
- Human skin
- Hypnotic
- Iloprost
- Immune system
- Immune thrombocytopenic purpura
- Immunoglobulin therapy
- Immunostimulant
- Immunosuppressive drug
- Immunotherapy
- Indication
- Infection
- International Chemical Identifier
- Intravenous therapy
- Jmol
- Joint
- KEGG
- Kidney failure
- Krąków
- Laxative
- Lead compound
- Lek
- Lipid-lowering agent
- Liver disease
- Local anesthetic
- Long COVID
- Low molecular weight heparin
- Lub
- Lumbrokinase
- Malignant
- Medication
- MedlinePlus
- Metabolism
- Mineral
- Mineralocorticoid
- Moisturizer
- Molar mass
- Mood stabilizer
- Muscle
- Muscle relaxant
- Myocardial infarction
- Nadroparin calcium
- Nafamostat
- Nattokinase
- Nervous system
- Neuroprotection
- Neurotoxin
- Nonsteroidal anti-inflammatory drug
- Nootropic
- Nucleoside
- Nucleotide
- Obesity
- Oligosaccharide
- Ophthalmology
- Orexigenic
- Otology
- Oxalate
- P2Y12
- Partial thromboplastin time
- Percutaneous aortic valve replacement
- Pharmacokinetics
- Pharmacology
- Pharmacophore
- Phases of clinical research
- Phenindione
- Phenprocoumon
- Phosphodiesterase inhibitor
- Placenta
- Plasma protein binding
- Plasminogen activator
- Platelet
- PMC
- Postmarketing surveillance
- Prasugrel
- Pregnancy category
- Prescription drug
- Prostacyclin
- Prostaglandin analogue
- Protein C
- Proton-pump inhibitor
- Psoriasis
- Psychedelic drug
- PubChem
- PubMed
- Pulmonary hemorrhage
- Rabbit
- Radiopharmacology
- Rat
- REG1
- Regulation of therapeutic goods
- Renin–angiotensin system
- Respiratory system
- Reteplase
- Rivaroxaban
- Route of administration
- Sedative
- Selective serotonin reuptake inhibitor
- Semaglutide
- Senotherapeutics
- Serenic
- Serine protease
- Sex steroid
- Statin
- Stimulant
- Streptokinase
- Stroke
- Sulodexide
- Tenecteplase
- Thrombin
- Thrombolysis
- Thrombosis
- Thromboxane
- Thromboxane receptor
- Thrombus
- Thyroid hormones
- Ticagrelor
- Ticlopidine
- Tinzaparin sodium
- Tissue plasminogen activator
- Topoisomerase inhibitor
- Treprostinil
- Triflusal
- University of Edinburgh
- Unstable angina
- Urokinase
- Vaccine
- Vasodilation
- Virtual screening
- Vitamin
- Vita Sulla
- Vorapaxar
- W
- Warfarin
- WHO Model List of Essential Medicines
- Ximelagatran